UNIVERSITY OF SAN DIEGO

Their core work

The University of San Diego is a private university in California, USA, engaged in research and doctoral-level education spanning neuroscience and engineering. In the H2020 context, USD participated exclusively as a third-party partner in Marie Skłodowska-Curie Actions (MSCA), meaning they hosted visiting researchers or provided training capacity rather than leading funded work. Their two projects span brain barrier biology and smart manufacturing — two distinct domains, suggesting USD offered specific departmental expertise to European consortium builders rather than a single unified research agenda. As a non-EU institution, USD received no direct EC funding but contributed knowledge exchange and mobility hosting to multinational research networks.

What they specialise in

How they've shifted over time

With only two projects, both concentrated in the 2015–2016 start window and carrying no extractable keywords, meaningful evolution analysis is not possible from this dataset alone. Both projects were active simultaneously and reflect a snapshot of USD's European engagement in the mid-2010s rather than a longitudinal trend. No post-2019 H2020 activity appears in the data, so whether USD deepened either domain or shifted focus entirely cannot be determined here.

USD's H2020 record ends in 2018–2019 with no follow-on projects visible, making it unclear whether their European research engagement continued, expanded, or was a one-time alignment with specific MSCA consortia.

How they like to work

USD participated exclusively as a third-party in both projects — a role typical for US universities in MSCA schemes, where full beneficiary status is restricted to EU/associated countries. This means USD joined at the invitation of European coordinators rather than initiating partnerships independently. Despite this peripheral formal role, they connected with 38 partners across 12 countries through just two projects, suggesting they were embedded in large, well-networked MSCA consortia rather than small bilateral exchanges.

USD reached 38 unique consortium partners across 12 countries through only 2 projects — a high ratio driven by the large consortium structures typical of MSCA-ITN and MSCA-RISE schemes. Their network is European-facing but anchored in the US, positioning them as a transatlantic node for researcher exchange rather than a European consortium hub.

What sets them apart

USD's value to European consortium builders is primarily as a US-based training and mobility host, providing researchers with access to American academic infrastructure and networks without requiring direct EU funding. Their simultaneous presence in both neuroscience (BtRAIN) and manufacturing (MAKERS) suggests they offer a multi-faculty capacity rather than a single-discipline niche. For an MSCA consortium needing a credible US partner institution with transatlantic reach, USD fits that structural slot.

Highlights from their portfolio

• BtRAIN
  A multi-year MSCA doctoral training network (ITN-ETN) on brain barriers — a specialized and competitive funding scheme — indicating USD was vetted as a quality training environment by a pan-European neuroscience consortium.
• MAKERS
  An MSCA-RISE project on smart manufacturing connecting EU and non-EU institutions through research exchanges, notable for USD's inclusion as the sole or one of few US partners bridging European industrial research to the American academic context.